Lsv Asset Management’s Bristol-Myers Squibb Co Position
Does Lsv Asset Management own Bristol-Myers Squibb Co (BMY)? Yes — 8.86M shares worth $537M (+1.16% of its 13F portfolio) as of Q1 2026, up from 8.65M shares the prior filed quarter.
Position Value
$537M
Q1 2026
Shares
8.86M
% of Portfolio
+1.16%
Quarters Held
29
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 8.86M | $537M | +1.16% |
| Q4 2025 | 8.65M | $467M | +1.02% |
| Q3 2025 | 8.27M | $373M | +0.82% |
| Q2 2025 | 8.13M | $376M | +0.88% |
| Q1 2025 | 8.12M | $495M | +1.19% |
| Q4 2024 | 8.32M | $471M | +1.09% |
| Q3 2024 | 8.55M | $442M | +0.95% |
| Q2 2024 | 8.28M | $344M | +0.75% |
| Q1 2024 | 8.53M | $463M | +0.96% |
| Q4 2023 | 8.74M | $448M | +0.98% |
| Q3 2023 | 9.00M | $522M | +1.21% |
| Q2 2023 | 9.40M | $601M | +1.33% |
| Q1 2023 | 9.40M | $652M | +1.46% |
| Q4 2022 | 9.44M | $680M | +1.50% |
| Q3 2022 | 9.92M | $705M | +1.66% |
| Q2 2022 | 9.98M | $768M | +1.66% |
| Q1 2022 | 10.24M | $748M | +1.37% |
| Q4 2021 | 10.16M | $634M | +1.12% |
| Q3 2021 | 10.47M | $620M | +1.12% |
| Q2 2021 | 10.64M | $711M | +1.21% |
| Q1 2021 | 10.56M | $666M | +1.14% |
| Q4 2020 | 11.10M | $689M | +1.25% |
| Q3 2020 | 11.58M | $698M | +1.43% |
| Q2 2020 | 11.32M | $666M | +1.38% |
| Q1 2020 | 9.77M | $545M | +1.32% |
| Q4 2019 | 9.74M | $625M | +0.97% |
| Q3 2019 | 3.83M | $194M | +0.32% |
| Q2 2019 | 168.6K | $8M | +0.01% |
| Q1 2019 | 168.6K | $8M | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lsv Asset Management’s full portfolio or all institutional holders of BMY.